TCTR20210909002尚未招募2 期
Post-Exposure Prophylaxis with Favipiravir among Household Close Contacts to Confirmed COVID-19 cases: Cluster-Randomized Trial
适应症
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 入组人数
- 156
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 7 Years 至 N/A (No limit)（—）
- 性别
- All
入选标准
- •1. age equal or more than 7-year-old
- •2. Close contact with SARS-CoV-2 index case confirmed with SARS-CoV-2 PCR
- •3. Contact with index case less than 72 hours before enrollment
- •4. Comminacability by electronic module
排除标准
- •1. Household contacts who have symptoms compatible with SARS-CoV-2 infection definition or SARS-CoV-2 PCR showed a positive result.
- •2. Previous receiving favipiravir in 14 days
- •3. Contraindication of favipiravir treatment
- •4. Pregnancy in any trimester
- •5. Allergy to favipiravir
- •6. Moderate to severe liver disease
研究者
相似试验
进行中（未招募）
不适用
HIV postexposure prophylaxis with Darunavir/r (PEPDar)HIV postexposure prophylaxisMedDRA version: 14.1Level: PTClassification code 10054925Term: Prophylaxis against HIV infectionSystem Organ Class: 10042613 - Surgical and medical proceduresEUCTR2011-001303-13-DEJanssen Cilag
已完成
不适用
ncontrolled study of post-exposure prophylaxis for influenza by peramivirPatients exposed to influenzaJPRN-UMIN000014519Hokkaido University Hospital, Infection Control Team10
尚未招募
4 期
The effectiveness of HIV preventive methods in Brazilian health serviceC02.782.815.616.400HIV InfectionsRBR-2qfjpvDepartamento de Medicina Preventiva, Faculdade de Medicina, Universidade de São Paulo
撤回
4 期
Hepatitis C Virus Post-Exposure Prophylaxis for Health Care WorkersViral Hepatitis CNCT01766115Massachusetts General Hospital
招募中
3 期
Prophylactic Favipiravir for Healthcare Workers in COVID-19 PandemicIRCT20150107020592N30Vice chancellor for research, Shahid Beheshti university of medical sciences30